Antiphospholipid Syndrome Antiphospholipid antibodies can induce endothelial-cell,
complement, platelet, neutrophil, and monocyte activation, leading to thrombosis, renal …

Objective To perform a systematic review of the literature regarding the epidemiology of the
association between systemic lupus erythematosus (SLE) and atherosclerotic …

Background Cigarette smoking and abnormal serum cholesterol concentrations are risk
factors for acute coronary syndromes, but the underlying mechanisms are poorly …

The antiphospholipid syndrome is an autoimmune disorder of hypercoagulability
characterized by the presence of autoantibodies to various phospholipids or phospholipid …

To formally establish the risk of lupus anticoagulants and anticardiolipin antibodies for
arterial and venous thrombosis, we ran a MEDLINE search of the literature from 1988 to …

Background Arterial thrombosis is a major clinical manifestation of the antiphospholipid
syndrome, which is an autoimmune disease found mostly in young women. Although the …

antibodies concomitant with larger atherosclerotic lesions that contained abundant CD4
cells. OxLDL is the type of LDL that is more likely to undergo uptake by macrophages, which …

Epidemiology of the Antiphospholipid Antibody Syndrome Page 1 Journal of Autoimmunity (2000)
15, 145–151 doi:10.1006/jaut.2000.0409, available online at http://www.idealibrary.com on …

Accumulating evidence shows that SARS‐CoV‐2 can potentially trigger autoimmune
processes, which can be responsible for the long‐term consequences of COVID‐19 …

Atherosclerosis is a pathologic process affecting blood vessels, which leads to the
development of cardiovascular disease. The immune system is involved in atherogenesis …